2012
DOI: 10.1021/om300501d
|View full text |Cite
|
Sign up to set email alerts
|

Organometallic Complexes for SPECT Imaging and/or Radionuclide Therapy

Abstract: This article reviews Re and Tc organometallic chemistry and radiochemistry, focusing on the most relevant aspects to design radiotools for molecular imaging and therapy. The review comprises an overview of organometallic Re and Tc complexes with relevance to the field, particularly M(I) tricarbonyl complexes stabilized by a huge variety of ligands. These include Werner type chelators, cyclopentadienyls, carboranes, and poly(mercaptoazolyl)borates, which permitted the hitherto unprecedented use of M–C and M–H b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
51
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 83 publications
(51 citation statements)
references
References 232 publications
0
51
0
Order By: Relevance
“…Technetium(I) and Rhenium(I) compounds, especially the aqueous complexes, have recently assumed an important role for diagnostic and therapeutic applications . In particular, the development of a one‐pot synthetic procedure to prepare in mild conditions organometallic M(I)‐tricarbonyl complexes (M=Tc or Re) has stimulated a growing interest towards these compounds for the applications in nuclear medicine.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations
“…Technetium(I) and Rhenium(I) compounds, especially the aqueous complexes, have recently assumed an important role for diagnostic and therapeutic applications . In particular, the development of a one‐pot synthetic procedure to prepare in mild conditions organometallic M(I)‐tricarbonyl complexes (M=Tc or Re) has stimulated a growing interest towards these compounds for the applications in nuclear medicine.…”
Section: Introductionmentioning
confidence: 99%
“…In particular, the development of a one‐pot synthetic procedure to prepare in mild conditions organometallic M(I)‐tricarbonyl complexes (M=Tc or Re) has stimulated a growing interest towards these compounds for the applications in nuclear medicine. Radiopharmaceuticals based on 99m Tc(I)‐tricarbonyl complexes have been widely explored as imaging agents, whereas 186 Re(I) and 188 Re(I) compounds have been mainly investigated for therapeutic purposes . Furthermore, the spectral properties of Rhenium(I) tricarbonyl complexes have been exploited in fluorescence microscopy…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…somatostatin derivatives for neuroendocrine tumours, other promising candidates such as neuropeptide Y (NPY), c(RCDyK), c(RCDfK), Lys3-BBN, monocyte chemotactic peptide-1 and MG (minigastrin) are amongst the subjects of current preclinical evaluation. 8,9 Small, synthetic, receptor-binding peptides are excellent vectors for specific receptor-imaging, primarily due to the availability of numerous peptides with a broad range of biological activities against many chronic diseases and their favourable pharmacokinetic characteristics, especially combined with their flexibility in chemical modification and radiolabeling. The high binding affinity of a peptide for its receptor induces its retention in receptor over-expressing tissues.…”
Section: Introductionmentioning
confidence: 99%